Page last updated: 2024-10-26

doxepin and Cardiotoxicity

doxepin has been researched along with Cardiotoxicity in 1 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, H1
Kang, H1
An, JR1
Seo, MS1
Jung, WK1
Lee, DS1
Choi, G1
Yim, MJ1
Lee, JM1
Bae, YM1
Son, YK1
Choi, IW1
Park, WS1

Other Studies

1 other study available for doxepin and Cardiotoxicity

ArticleYear
Inhibitory Effect of Tricyclic Antidepressant Doxepin on Voltage-Dependent K
    Cardiovascular toxicology, 2019, Volume: 19, Issue:5

    Topics: Animals; Antidepressive Agents, Tricyclic; Cardiotoxicity; Coronary Vessels; Doxepin; Membrane Poten

2019